Robert G. Lerner, M.D.

In the past three years, Dr. Lerner has served as a consultant for RPR, and has served on the Speakers' Bureau for Pharmacia & Upjohn.

Release Date: 09/28/2002
Termination Date: 09/28/2005

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Understand the meaning of the term "non-small cell lung cancer" (NSCLC)
• Discuss The Revised International Staging System for Lung Cancer
• Discuss the therapeutic options -- surgery, radiation or chemotherapy -- and their effectiveness vis a vis this disease
• List the many different chemotherapeutic agents that are effective for this group of tumors
• Recognize that although palliation and prolongation of survival can be achieved, even in far advanced or recurrent cases, there is no single standard regimen and participation in trials should be considered.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity